Trump Orders Dedicated NIH Women's Health Division and Task Force

President Donald Trump signed an executive order directing the establishment of a dedicated Women's Health Division within the National Institutes of Health. The presidential directive instructs the Department of Health and Human Services to establish the specialized scientific research division within 90 days. The executive action simultaneously established a White House Women's Health Task Force to coordinate health research policy across federal executive agencies. First Lady Melania Trump played a central leadership role in championing the health overhaul through working sessions convened inside the East Wing.

The executive order directs the new division to develop accountability mechanisms for grant recipients to enforce compliance with the NIH policy requiring research to account for sex as a biological variable.

Mandate and Scope of New NIH Research Division

Federal health officials confirmed that the new division will operate alongside the existing Office of Research on Women's Health established in 1990. The newly established scientific unit will accelerate investigations into female cardiovascular disease, gynecological malignancies, autoimmune illnesses, and menopausal conditions. NIH Director Jay Bhattacharya stated that the division will address persistent evidence gaps and accelerate medical innovations directly to clinical care. The National Institutes of Health currently allocates approximately $5 billion annually to female-specific medical research, representing roughly ten percent of its agency budget.

The NIH Revitalization Act of 1993 confirmed the Office of Research on Women's Health in federal statute.

White House Task Force Leadership and Coordination

The newly chartered White House Women's Health Task Force will be co-chaired by Health and Human Services Secretary Robert F Kennedy Jr. White House Chief of Staff Susie Wiles will lead the interagency task force alongside federal healthcare administration directors. The task force is chartered to harmonize federal scientific initiatives spanning infancy, adolescent development, maternal childbearing years, midlife, and elder care.

East Wing Advocacy and Policy Precedents

First Lady Melania Trump conducted policy meetings with clinical researchers and medical experts to design the administrative framework for the health directive. Melania Trump declared that national research efforts must serve women through every stage of life, from young adulthood to motherhood and senior years. The health directive builds upon executive policy measures implemented by the Department of Health and Human Services since January 2025. The initiative expands upon historical federal precedent, including a March 2024 executive order signed by President Joe Biden targeting cardiovascular and menopausal research.

Implementation Timelines and Biomedical Objectives

The Department of Health and Human Services initiated operational planning to integrate research grant allocations across NIH biological institutes within the designated 90-day window. Federal health agencies intend to prioritize personalized clinical medicine, advanced biomarker testing, and maternal health research under the unified national division.